Low Dose Aspirin Alerts in High-Risk Pregnancies

Completed · Not applicable

Conditions studied: Preeclampsia, Aspirin, Clinical Decision Support Systems, Economics, Behavioral

In brief

The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize that the implementation of the EHR BPA tool will increase the healthcare provider's recommendation for low dose aspirin compared to current standard care.

Key facts

Study ID

NCT05802940

Run by

Geisinger Clinic

People needed

830

Starts

2023-06-19

Expected to finish

2026-01-27

Last updated by the study team

2026-07-23

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Receiving prenatal care within Geisinger
• Initial prenatal visit prior to 28 weeks gestation
• Determined to be high risk for preeclampsia based on the modified United States Preventive Services Task Force and American College of Obstetrics and Gynecology criteria (at least 1 high risk factor)

You may not qualify if…

• Not pregnant
• No prenatal visit prior to 28 weeks gestation
• Maternal-Fetal Medicine only visits
• Not meeting the modified USPSTF high-risk criteria
• Contraindication to aspirin, including allergy

Where it is running

• Geisinger Medical Center — Danville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.